โ† Back

Clear.bio ๐Ÿ‡ณ๐Ÿ‡ฑ

Venture round

Digital health solution helping people with type 2 diabetes manage blood sugar through personalized dietary insights.

About Clear.bio

Clear.bio offers a digital health solution designed to help individuals with type 2 diabetes manage their condition through personalized dietary insights. Utilizing a real-time blood glucose sensor and a mobile app, the service tracks users' food intake and provides tailored recommendations based on their unique physiological responses to nutrition.

Clear.bio is a Netherlands-based company founded in 2019, now around 17 people. It has raised $4.1M in disclosed funding. FundFinder classes it as Health & Bio.

Founded by Piet Hein Van Dam (CEO and founder; previously Avalex, ING; University of Amsterdam), Madelon Bracke (Chief Scientific Officer & Cofounder; repeat founder; previously Cancer Research UK (CRUK), Catalpa Matrix Biology; MBI Life Sciences & Health), Mostafa Sakr (CTO and Co-Founder; previously AG Soft, Allshare; Beni-Suef University).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Clear.bio? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Venture round ยท Sep 2025

  • Mustard Seed MAZE โ€” Investing in the great businesses of the future, those that solve social and environmental challenges. ยท cheques ยฃ100k โ€“ ยฃ1M
Raising your own round? See which European funds fit โ†’